Skip to main content
Erschienen in: Journal of Endocrinological Investigation 9/2014

01.09.2014 | Original Article

Isolated hyperthyrotropinemia in childhood obesity and its relation with metabolic parameters

verfasst von: Tolga Ünüvar, Ahmet Anık, Gönül Çatlı, İhsan Esen, Ayhan Abacı, Atilla Büyükgebiz, Ece Böber

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of the presented study was to evaluate the prevalence of isolated hyperthyrotropinemia (IH) in obese children and the relation between anthropometric and metabolic parameters.

Methods

Hospital records of the children, who presented to the Pediatric Endocrinology outpatient clinic of our institution with obesity, and age and gender-matched healthy children, who had undergone thyroid function test for any reason were retrospectively reviewed.

Results

The prevalence of IH was significantly higher in the obese group than in the controls (9.2 and 3.8 %, respectively). Body mass index-standard deviation score (BMI-SDS), thyroid-stimulating hormone (TSH), lipid parameters were significantly different in the obese group than in the control group. A positive correlation between TSH and BMI-SDS and negative correlation between TSH and free T4 (fT4) levels were found in obese subjects. Stepwise multiple linear regression analysis confirmed that BMI-SDS, fT4 and triglyceride levels were the strongest independent variables correlated with TSH level in obese subjects (r 2 = 0.046, p = 0.001).

Conclusions

IH prevalence is higher in obese children as compared to healthy children and the increase in TSH level correlates negatively with serum fT4 and positively with BMI-SDS and triglyceride levels in obese children.
Literatur
3.
Zurück zum Zitat Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F (2005) Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol 62(4):487–491. doi:10.1111/j.1365-2265.2005.02247.x CrossRef Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F (2005) Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol 62(4):487–491. doi:10.​1111/​j.​1365-2265.​2005.​02247.​x CrossRef
5.
6.
Zurück zum Zitat Stichel H, l’Allemand D, Gruters A (2000) Thyroid function and obesity in children and adolescents. Horm Res 54(1):14–19PubMedCrossRef Stichel H, l’Allemand D, Gruters A (2000) Thyroid function and obesity in children and adolescents. Horm Res 54(1):14–19PubMedCrossRef
7.
Zurück zum Zitat Tagliaferri M, Berselli ME, Calo G, Minocci A, Savia G, Petroni ML, Viberti GC, Liuzzi A (2001) Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res 9(3):196–201. doi:10.1038/oby.2001.21 PubMedCrossRef Tagliaferri M, Berselli ME, Calo G, Minocci A, Savia G, Petroni ML, Viberti GC, Liuzzi A (2001) Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res 9(3):196–201. doi:10.​1038/​oby.​2001.​21 PubMedCrossRef
9.
Zurück zum Zitat Rotondi M, Leporati P, La Manna A, Pirali B, Mondello T, Fonte R, Magri F, Chiovato L (2009) Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol/Eur Fed Endocr Soc 160(3):403–408. doi:10.1530/EJE-08-0734 CrossRef Rotondi M, Leporati P, La Manna A, Pirali B, Mondello T, Fonte R, Magri F, Chiovato L (2009) Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol/Eur Fed Endocr Soc 160(3):403–408. doi:10.​1530/​EJE-08-0734 CrossRef
11.
Zurück zum Zitat Cole TJ (1990) The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44(1):45–60PubMed Cole TJ (1990) The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44(1):45–60PubMed
12.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419PubMedCrossRef
13.
Zurück zum Zitat Valerio G, Licenziati MR, Iannuzzi A, Franzese A, Siani P, Riccardi G, Rubba P (2006) Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis NMCD 16(4):279–284. doi:10.1016/j.numecd.2005.12.007 CrossRef Valerio G, Licenziati MR, Iannuzzi A, Franzese A, Siani P, Riccardi G, Rubba P (2006) Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis NMCD 16(4):279–284. doi:10.​1016/​j.​numecd.​2005.​12.​007 CrossRef
15.
Zurück zum Zitat D’Adamo E, De Leonibus C, Giannini C, Corazzini V, De Remigis A, Chiarelli F, Mohn A (2012) Thyroid dysfunction in obese pre-pubertal children: oxidative stress as a potential pathogenetic mechanism. Free Radic Res 46(3):303–309. doi:10.3109/10715762.2011.653967 PubMedCrossRef D’Adamo E, De Leonibus C, Giannini C, Corazzini V, De Remigis A, Chiarelli F, Mohn A (2012) Thyroid dysfunction in obese pre-pubertal children: oxidative stress as a potential pathogenetic mechanism. Free Radic Res 46(3):303–309. doi:10.​3109/​10715762.​2011.​653967 PubMedCrossRef
16.
Zurück zum Zitat Emokpae MA, Adeleke SI, Uwumarongie HO (2011) Subclinical hypothyroidism in childhood obesity and its correlation with lipoproteins. Afr J Med Med Sci 40(4):361–365PubMed Emokpae MA, Adeleke SI, Uwumarongie HO (2011) Subclinical hypothyroidism in childhood obesity and its correlation with lipoproteins. Afr J Med Med Sci 40(4):361–365PubMed
18.
Zurück zum Zitat Marras V, Casini MR, Pilia S, Carta D, Civolani P, Porcu M, Uccheddu AP, Loche S (2010) Thyroid function in obese children and adolescents. Horm Res Paediatr 73(3):193–197. doi:10.1159/000284361 PubMedCrossRef Marras V, Casini MR, Pilia S, Carta D, Civolani P, Porcu M, Uccheddu AP, Loche S (2010) Thyroid function in obese children and adolescents. Horm Res Paediatr 73(3):193–197. doi:10.​1159/​000284361 PubMedCrossRef
19.
Zurück zum Zitat Shalitin S, Yackobovitch-Gavan M, Phillip M (2009) Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic parameters. Horm Res 71(3):155–161. doi:10.1159/000197872 PubMedCrossRef Shalitin S, Yackobovitch-Gavan M, Phillip M (2009) Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic parameters. Horm Res 71(3):155–161. doi:10.​1159/​000197872 PubMedCrossRef
20.
Zurück zum Zitat Aypak C, Turedi O, Yuce A, Gorpelioglu S (2013) Thyroid-stimulating hormone (TSH) level in nutritionally obese children and metabolic co-morbidity. J Pediatr Endocrinol Metab JPEM 26(7–8):703–708. doi:10.1515/jpem-2012-0384 Aypak C, Turedi O, Yuce A, Gorpelioglu S (2013) Thyroid-stimulating hormone (TSH) level in nutritionally obese children and metabolic co-morbidity. J Pediatr Endocrinol Metab JPEM 26(7–8):703–708. doi:10.​1515/​jpem-2012-0384
22.
Zurück zum Zitat Aeberli I, Jung A, Murer SB, Wildhaber J, Wildhaber-Brooks J, Knopfli BH, Zimmermann MB (2010) During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat. J Clin Endocrinol Metab 95(12):5412–5418. doi:10.1210/jc.2010-1169 PubMedCrossRef Aeberli I, Jung A, Murer SB, Wildhaber J, Wildhaber-Brooks J, Knopfli BH, Zimmermann MB (2010) During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat. J Clin Endocrinol Metab 95(12):5412–5418. doi:10.​1210/​jc.​2010-1169 PubMedCrossRef
23.
Zurück zum Zitat Sert A, Pirgon O, Aypar E, Yilmaz H, Odabas D (2013) Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease. Pediatr Cardiol 34(5):1166–1174. doi:10.1007/s00246-013-0638-z PubMedCrossRef Sert A, Pirgon O, Aypar E, Yilmaz H, Odabas D (2013) Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease. Pediatr Cardiol 34(5):1166–1174. doi:10.​1007/​s00246-013-0638-z PubMedCrossRef
24.
Zurück zum Zitat Radetti G, Longhi S, Baiocchi M, Cassar W, Buzi F (2012) Changes in lifestyle improve body composition, thyroid function, and structure in obese children. J Endocrinol Invest 35(3):281–285. doi:10.3275/7763 PubMed Radetti G, Longhi S, Baiocchi M, Cassar W, Buzi F (2012) Changes in lifestyle improve body composition, thyroid function, and structure in obese children. J Endocrinol Invest 35(3):281–285. doi:10.​3275/​7763 PubMed
25.
Zurück zum Zitat Galofre JC, Pujante P, Abreu C, Santos S, Guillen-Grima F, Fruhbeck G, Salvador J (2008) Relationship between thyroid-stimulating hormone and insulin in euthyroid obese men. Ann Nutr Metab 53(3–4):188–194. doi:10.1159/000172981 PubMed Galofre JC, Pujante P, Abreu C, Santos S, Guillen-Grima F, Fruhbeck G, Salvador J (2008) Relationship between thyroid-stimulating hormone and insulin in euthyroid obese men. Ann Nutr Metab 53(3–4):188–194. doi:10.​1159/​000172981 PubMed
26.
Zurück zum Zitat Kim BJ, Kim TY, Koh JM, Kim HK, Park JY, Lee KU, Shong YK, Kim WB (2009) Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol 70(1):152–160. doi:10.1111/j.1365-2265.2008.03304.x CrossRef Kim BJ, Kim TY, Koh JM, Kim HK, Park JY, Lee KU, Shong YK, Kim WB (2009) Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol 70(1):152–160. doi:10.​1111/​j.​1365-2265.​2008.​03304.​x CrossRef
27.
Zurück zum Zitat Bastemir M, Akin F, Emral R, Alkis E (2007) Impact of insulin sensitivity in relationship with prolactin and thyroid stimulating hormone. Exp Clin Endocrinol Diabetes Off J German Soc Endocrinol German Diabetes Assoc 115(4):257–260. doi:10.1055/s-2007-960492 CrossRef Bastemir M, Akin F, Emral R, Alkis E (2007) Impact of insulin sensitivity in relationship with prolactin and thyroid stimulating hormone. Exp Clin Endocrinol Diabetes Off J German Soc Endocrinol German Diabetes Assoc 115(4):257–260. doi:10.​1055/​s-2007-960492 CrossRef
28.
Zurück zum Zitat Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M, Mitrou P, Lambadiari V, Boutati E, Nikzas D, Tountas N, Economopoulos T, Raptis SA, Dimitriadis G (2009) Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol/Eur Fed Endocr Soc 160(5):785–790. doi:10.1530/EJE-08-0797 CrossRef Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M, Mitrou P, Lambadiari V, Boutati E, Nikzas D, Tountas N, Economopoulos T, Raptis SA, Dimitriadis G (2009) Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol/Eur Fed Endocr Soc 160(5):785–790. doi:10.​1530/​EJE-08-0797 CrossRef
Metadaten
Titel
Isolated hyperthyrotropinemia in childhood obesity and its relation with metabolic parameters
verfasst von
Tolga Ünüvar
Ahmet Anık
Gönül Çatlı
İhsan Esen
Ayhan Abacı
Atilla Büyükgebiz
Ece Böber
Publikationsdatum
01.09.2014
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 9/2014
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0100-y

Weitere Artikel der Ausgabe 9/2014

Journal of Endocrinological Investigation 9/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

NSCLC: Progressionsfreies Überleben unter Osimertinib fast versiebenfacht

06.06.2024 ASCO 2024 Kongressbericht

Erste Ergebnisse der Phase-III-Studie LAURA etablieren Osimertinib als neuen Therapiestandard für Menschen mit nicht-resezierbarem, EGFR-mutiertem, nicht-kleinzelligem Lungenkarzinom im Stadium III, die nach definitiver Radiochemotherapie progressionsfrei sind. Auf der ASCO-Tagung wurden diese beeindruckenden Ergebnisse besprochen.

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gute molekulare Response, aber seltener ernste Nebenwirkungen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.